Enbrel Promotions May Use AUC Data, Erosion Scores, Not Superiority Claims
• By The Pink Sheet
Immunex' Enbrel promotions may use data on percentages of patients with no increase in erosion scores and area under the curve data, but may not use the data to make superiority claims to methotrexate, the approval letter for a new indication for Enbrel states.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
